US Patent Issued to The General Hospital, President and Fellows of Harvard College on Jan. 13 for "Methods and materials for modulating Nrf2 pathway" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,439, issued on Jan. 13, was assigned to The General Hospital Corp. (Boston) and President and Fellows of Harvard College (Cambridge, Mass.).

"Methods and materials for modulating Nrf2 pathway" was invented by Bakhos Tannous (Lynnfield, Mass.), Christian Badr (Malden, Mass.), Ralph Mazitschek (Belmont, Mass.) and Neil Connor Payne (Madison, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides methods and compounds of modulating Nrf2 pathway. Methods for treating cancer and neurodegenerative conditions are also provided."

The patent was filed on Oct. 2, 2020, under Application No. 17/765,667.

*For further information...